Open Heart

JANUARY 31, 2022

Objectives To understand the patient and hospital level drivers of the variation in surgical versus trascatheter aortic valve replacement (SAVR vs TAVR) for patients with aortic stenosis (AS) and to explore whether this variation translates into differences in clinical outcomes. Background Adoption of TAVR has grown exponentially worldwide. Notwithstanding, a wide variation in TAVR rates has been seen within and between countries and in some jurisdictions AS is still primarily being managed by S

Aortic valve 52

Aortic valve TAVR Aortic Outcomes 52

Dr. Sanjay Gupta

JANUARY 25, 2022

The York Press A YORK heart specialist says he believes many Long Covid patients may actually have a condition called POTS – and could benefit from treatments used for patients with the syndrome. Dr Sanjay Gupta, a consultant cardiologist at York Hospital, is an expert in POTS, or postural tachycardia syndrome. The condition can leave sufferers debilitated, constantly exhausted, and sometimes unable even to walk.

POTS 52

POTS Hospital Chest Pain Blood Pressure 52

Society of Thoracic Surgeons - Technology

JANUARY 19, 2022

Press Release The Thoracic Surgery Foundation Awards Inaugural International Fellowships January 19, 2022 jbagley Wed, 01/19/2022 - 09:52 Cardiothoracic surgeons from the US and Italy receive practice-changing funding support CHICAGO (January 19, 2022)—Through a collaborative effort between The Society of Thoracic Surgeons (STS) and the European Association for Cardio-Thoracic Surgery (EACTS), two standout young surgeons recently each received $20,000 in fellowship grants to learn new techniques

Cardiothoracic 52

Cardiothoracic Heart Transplant Allied Health Education 52

ECG Cases

JANUARY 18, 2022

A few select videos from EM Cases Summit 2021 have been made FOAMed and available here and on our youtube channel. The latest release is with Dr. Rob Simard who explains the failings of the ACLS protocol for PEA arrest, how PoCUS pulse checks can help us differentiate true PEA from pseudoPEA, and how to integrate this information and our PoCUS skills into the flow of our cardiac arrest management.

CME 52

CME Cardiac Arrest 52

Dr. Smith's ECG Blog

JANUARY 3, 2022

This fantastic case and post was written by Jesse McLaren (@ECGcases), edited by Smith Case You’re shown an ECG from a patient in the waiting room with chest pain. What do you think? Sinus bradycardia, normal conduction, normal axis, normal R wave progression, no hypertrophy. There’s primary ST depression in the precordial leads maximal in V3-4, and an inverted T wave in V2.

STEMI 52

STEMI Myocardial Infarction Chest Pain Ischemia 52

SoftCath

JANUARY 2, 2022

In the last few years, we’ve witnessed a massive transformation in analytics in the cardiology department. No longer it’s only about digital dashboards, but technology is transforming all areas in Cath labs. One of the prime examples is Cath Lab Software. Such Cath lab solutions have had a disruptive impact as they provide a new way to mine relevant data, ensure quality, and pave the way for better overall management.

Electrophysiology 52

Electrophysiology Technology Pacemaker Hospital 52

Open Heart

JANUARY 31, 2022

Objective Coronary angiography (CA) and percutaneous coronary intervention (PCI) is of great importance during non-ST-segment elevation myocardial infarction (NSTEMI) management. Coronary artery lesions and their association to mortality in elderly patients with NSTEMI was investigated. Methods Patients >80 years of age who underwent CA at index NSTEMI during 2011–2014 were included.

Myocardial Infarction 52

Myocardial Infarction Stenosis Angioplasty Heart Disease 52

Open Heart

JANUARY 27, 2022

Objectives (1) To evaluate the prevalence and hospitalisation rate of COVID-19 infections among patients with dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) in the Royal Brompton and Harefield Hospital Cardiovascular Research Centre (RBHH CRC) Biobank. (2) To evaluate the indirect impact of the pandemic on patients with cardiomyopathy through the Heart Hive COVID-19 study. (3) To assess the impact of the pandemic on national cardiomyopathy-related hospital admissions.

COVID-19 52

COVID-19 Cardiomyopathy Hospital Heart Disease 52

Open Heart

JANUARY 27, 2022

Objective We previously reported early-onset atrial fibrillation (AF) associated genetic loci among a Korean population. We explored whether the AF-associated single-nucleotide polymorphisms (SNPs) selected from the Genome-Wide Association Study (GWAS) of an external large cohort has a prediction power for AF in Korean population through a convolutional neural network (CNN).

Atrial Fibrillation 52

Atrial Fibrillation 52

Open Heart

JANUARY 27, 2022

Background Early recognition of ST-segment elevation myocardial infarction (STEMI) is needed for timely cardiac monitoring and reperfusion therapy. Methods Three anonymously linked New Zealand national datasets (July 2016–November 2018) were used to assess the utilisation of ambulance transport in STEMI cases, the concordance between ambulance initial clinical impressions and hospital STEMI diagnoses, and the association between initial paramedic clinical impressions and 30-day mortality.

Myocardial Infarction 52

Myocardial Infarction STEMI Hospital 52

Open Heart

JANUARY 26, 2022

Objective To estimate the population prevalence and treatable burden of severe aortic stenosis (AS) in the UK. Methods We adapted a contemporary model of the population profile of symptomatic and asymptomatic severe AS in Europe and North America to estimate the number of people aged ≥55 years in the UK who might benefit from surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI).

Stenosis 52

Stenosis Aortic Aortic valve 52

Open Heart

JANUARY 21, 2022

Deficits in health literacy are common in patients with coronary artery disease (CAD), and this is associated with increased morbidity and mortality. In this scoping review, we sought to identify health literacy interventions that aimed to improve outcomes in patients with CAD, using a contemporary conceptual model that captures multiple aspects of health literacy.

Coronary Artery Disease 52

Coronary Artery Disease Outcomes 52

Open Heart

JANUARY 21, 2022

Objectives To describe the occurrence of significant pericardial effusion, and to investigate characteristics associated with pericardial effusion within three months following heart valve surgery. Methods A retrospective, observational cohort study including adult patients undergoing heart valve surgery at Odense University Hospital from August 2013 to November 2017.

Heart Valves 52

Heart Valves Coronary Artery Bypass Graft Aortic valve Bicuspid/Mitral 52

Open Heart

JANUARY 20, 2022

Background Cardiac arrhythmias have been observed among patients hospitalised with acute COVID-19 infection, and palpitations remain a common symptom among the much larger outpatient population of COVID-19 survivors in the convalescent stage of the disease. Objective To determine arrhythmia prevalence among outpatients after a COVID-19 diagnosis. Methods Adults with a positive COVID-19 test and without a history of arrhythmia were prospectively evaluated with 14-day ambulatory electrocardiograph

COVID-19 52

COVID-19 Arrhythmia Outpatient Atrial Flutter 52

Open Heart

JANUARY 19, 2022

Background Circulatory failure after out-of-hospital cardiac arrest (OHCA) as part of the postcardiac arrest syndrome (PCAS) is believed to be caused by an initial myocardial depression that later subsides into a superimposed vasodilatation. However, the relative contribution of myocardial dysfunction and systemic inflammation has not been established.

Cardiac Arrest 52

Cardiac Arrest Hospital Biomarkers Blood Pressure 52

ECG Cases

JANUARY 18, 2022

In this months EM Quick Hits podcast: Ken Milne expertly walks us through the 10 biggest EM papers of 2021, Brit Long on a careful structured approach to Febrile Neutropenia to improve outcomes, Catherine Varner on how not to miss Peripartum Cardiomyopathy, Joe Nemeth on Anaphylaxis update and Anand Swaminathan gives us his approach to the Crashing Asthmatic.

Cardiomyopathy 52

Cardiomyopathy Outcomes Pediatrics Stroke 52

Open Heart

JANUARY 11, 2022

Background The choice of antithrombotic therapy after percutaneous coronary intervention (PCI) is heavily dependent on the relative trade-off between major bleeding (MB) and myocardial infarction (MI). However, the mortality trade-off was mostly described in Western populations and remained unknown in East Asians. Method This was a retrospective cohort study from 14 hospitals under the Hospital Authority of Hong Kong between 2004 and 2017.

Myocardial Infarction 52

Myocardial Infarction Hospital 52

Open Heart

JANUARY 6, 2022

Background Percutaneous coronary intervention (PCI), the preferred coronary reperfusion strategy, induces endothelial trauma which may mount an inflammatory response. This has been shown to increase the likelihood of further major adverse cardiovascular events (MACE). Colchicine, a cheap and widely used anti-inflammatory has shown promise in improving cardiovascular outcomes.

Coronary Artery Disease 52

Coronary Artery Disease Thrombosis Stent Stents 52

Open Heart

JANUARY 6, 2022

Background The limited availability of balloon sizes for cryoballoon leads to anatomical limitations for pulmonary vein (PV) isolation. We conducted a comprehensive systematic analysis on procedural success rate, atrial fibrillation (AF) recurrence rate and complications of cryoballoon ablation in association with the anatomy of the left atrium and PV based on preprocedural CT to gain insights into proper treatments of patients with AF using cryoballoon.

Ablation 52

Ablation Atrial Fibrillation Anatomy Article 52

ECG Cases

JANUARY 4, 2022

What is the preferred order of vasopressors and ionotropes in the management of cardiogenic shock? In which patients would dobutamine be preferred over milrinone and vice versa? How can we best pick up occult cardiogenic shock before it floured shock kicks in? What are the best strategies to efficiently get the patient in cardiogenic shock to definitive care, whether that be the cath lab or the operating room?

Cardiogenic Shock 52

Cardiogenic Shock Heart Failure Aortic Stenosis 52

Open Heart

JANUARY 24, 2022

Aims Left atrial (LA) enlargement is an independent risk factor for atrial fibrillation (AF). Interestingly, some athletes have increased risk of AF, which may be linked to LA enlargement; however, little is known about the relationship between LA enlargement and AF risk at moderate-level physical activity (PA). We aimed to explore the associations between PA, LA size and risk of incident AF, and if PA can attenuate the risk of AF with LA enlargement.

Atrial Fibrillation 40

Atrial Fibrillation Risk Factors Hospital 40

Open Heart

JANUARY 24, 2022

Non-rheumatic aortic stenosis (AS) is among the most common valvular diseases in the developed world. Current guidelines support aortic valve replacement (AVR) for severe symptomatic AS, which carries high morbidity and mortality when left untreated. In contrast, moderate AS has historically been thought to be a benign diagnosis for which the potential benefits of AVR are outweighed by the procedural risks.

Stenosis 40

Stenosis Aortic Aortic valve Outcomes 40

Open Heart

JANUARY 6, 2022

Thicker carotid intima–media thickness (CIMT) has been a valid predictor for atherosclerosis development. A significant association between environmental tobacco smoke (ETS) and thickening of CIMT has been demonstrated in adults, whereas such association has scarcely been reviewed in paediatric population. The dominate electronic databases, including MEDLINE (Ovid), PubMed, Embase, CINAHL, Web of Science, Scopus, were searched from inception.

Article 40

Article Atherosclerosis Cardiovascular Disease 40

Open Heart

JANUARY 5, 2022

Objective Patients with low-flow, low-gradient aortic stenosis (LFLG AS) and reduced left ventricular ejection fraction (LVEF) are known to suffer from poor prognosis after transcatheter aortic valve implantation (TAVI). This study aimed to develop a simple score system for risk prediction in this vulnerable subset of patients. Methods All patients with LFLG AS with reduced EF and sufficient CT data for aortic valve calcification (AVC) quantification, who underwent TAVI at five German centres, w

Stenosis 52

Stenosis Aortic Aortic valve Atrial Fibrillation 52

Open Heart

JANUARY 21, 2022

Objectives Diastolic dysfunction (DD) has been reported to be highly prevalent in people living with HIV (PLWH) on antiretroviral therapy (ART) leading to the hypothesis that it may be an early marker of myocardial disease. Our objective was to evaluate the prevalence of DD in people living with human immunodeficiency virus without known history of diabetes or hypertension in Western Kenya.

Risk Factors 52

Risk Factors Blood Pressure Hypertension Diabetes 52

Open Heart

JANUARY 19, 2022

Objectives To determine the prevalence and types of viral pathogens in the myocardium of patients presenting with clinically suspected myocarditis in South Africa. Method This is a prospective cross-sectional study. Consecutive adults presenting to a single tertiary centre in South Africa between August 2017 and January 2021 who fulfilled the European Society of Cardiology’s diagnostic criteria for clinically suspected myocarditis and who had undergone the appropriate investigations, inclu

52

52